Development and Testing of Novel Metabolic Interventions for Severe Mental Illness

Working closely with the James Lind alliance and The McPin Foundation, this workstream will co-develop and assess the acceptability and therapeutic potential of a range of metabolic interventions as novel treatments for severe mental illness including digital approaches, chrononutrition (time restricted eating), the ketogenic diet, low carb diets, metformin and GLP1 receptor antagonists. This work will prioritise and co-design future clinical trials of metabolic interventions for SMI.

Meet the Team

  • Dr Iain Campbell

    Dr Iain Campbell

    Research Fellow in Metabolic Psychiatry, The University of Edinburgh

  • Professor Stephen Lawrie

    Professor Stephen Lawrie

    Professor of Psychiatry, The University of Edinburgh

  • Professor Khalida Ismail

    Professor Khalida Ismail (Co-Lead)

    Professor of Psychiatry & Medicine
    Institute of Psychiatry, Psychology & Neuroscience, King's College London

  • Dr Toby Pillinger

    Dr Toby Pillinger (Co-Lead)

    Clinical Lecturer, King's College London

  • Dr Dina Farran

    Dr Dina Farran

    Postdoctoral Researcher, King's College London

  • Professor Fiona Gaughran

    Professor Fiona Gaughran

    Professor of Physical Health & Clinical Therapeutics, Institute of Psychiatry, Psychology & Neuroscience, King's College London

  • Dr Annabel Walsh

    Dr Annabel Walsh

    Public Involvement in Research Manager, The McPin Foundation